Plant Comparison
Turmeric vs Field restharrow
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Turmeric and Field restharrow: they share 6 indicated uses (cancer (anticancer research), cardiovascular / heart health, infection (general), …); 5 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Turmeric | Field restharrow | Verdict |
|---|---|---|---|
| Cancer (anticancer research) | 1/10 | 2/10 | Comparable evidence |
| Cardiovascular / heart health | 3/10 | 2/10 | Comparable evidence |
| Infection (general) | 3/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 3/10 | 2/10 | Comparable evidence |
| Skin irritation | 3/10 | 2/10 | Comparable evidence |
| Wounds | 3/10 | 2/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal yellow-orange pigments and best-studied bioactive compounds, responsible for most of turmeric's anti-inflammatory and antioxidant activity; oral bioavailability is low unless combined with piperine or a lipid carrier.
Aromatic sesquiterpenes (including turmerone) contributing to fragrance and additional bioactivity.
Formononetin and its 7-O-glucoside ononin, plus related isoflavones - the signature restharrow constituents (also phytoestrogens).
Pterocarpans and isoflavanones and their glucosides, contributing to antimicrobial and wound-healing activity.
alpha-Onocerin (onocerin), a characteristic triterpene of the genus Ononis.
Caffeic, chlorogenic and p-coumaric acids (antioxidant).
A volatile oil present in the root and aerial parts.
Pharmacological Actions
Aquaretic diuretic; the classic irrigation-therapy action of restharrow root (Ononidis radix), used interchangeably for O. arvensis and O. spinosa.
Aqueous root extract reduced adhesion of uropathogenic E. coli to bladder cells (anti-adhesive).
Inhibits IL-8 release via TLR4/LPS and cytosolic phospholipase A2alpha (restharrow root).
Analgesic activity of Ononis extract in animals (congener O. spinosa).
Protective against ethanol-induced gastric mucosal injury (congener O. spinosa).
Ononis isoflavones showed chemopreventive/antiproliferative activity against breast cancer cells (preclinical).
Traditional & Indicated Uses
inferred from gastroprotective action
inferred from antidiabetic action
inferred from anticancer action
inferred from gastroprotective action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anticancer action
Aquaretic diuretic for irrigation therapy of the urinary tract.
Anti-adhesive activity against uropathogenic E. coli.
inferred from diuretic / urinary 'gravel' traditional use
inferred from diuretic (aquaretic) action
inferred from antimicrobial action
Isoflavonoid wound-healing agents from restharrow root.
inferred from anti-inflammatory and traditional skin/eczema use
Safety, Cautions & Contraindications
Generally very safe in culinary quantities. High-dose curcumin supplements may cause gastrointestinal upset. May interact with anticoagulants (warfarin), antidiabetic drugs, and acid-suppressing medications. Avoid very high doses during pregnancy and breastfeeding. Rarely causes allergic reactions.
Duke (2002) rates turmeric as +++ with clinical evidence (score 2) for anti-inflammatory activity, consistent with Commission E and WHO approvals. Curcumin is the primary bioactive compound with well-documented anti-inflammatory, antioxidant, anti-aggregant, and hepatoprotective effects. Duke notes Commission E approval for dyspeptic complaints. Dose: 1.5–3 g dried rhizome powder daily. A major pharmacological consideration is bioavailability: curcumin alone has low absorption, but combining with piperine (black pepper) increases bioavailability by up to 2000%. Contraindicated in bile duct obstruction; use with caution in gallstones and during pregnancy at medicinal doses (Duke, 2002).
A safety signal exists in the genus: an Ononis spinosa root extract showed hepatotoxic effects at higher doses in animals (alongside analgesic activity). Avoid excessive or prolonged use, and use caution in liver disease.
Used as an aquaretic for irrigation therapy of the urinary tract, restharrow should be taken with a generous fluid intake; it should NOT be used for 'flushing' when there is oedema due to impaired heart or kidney function (standard irrigation-therapy caution).
External Ids
Botanical Description
Rhizomatous perennial herb with large, broad, lance-shaped leaves arising directly from the underground rhizome in a clump. Pale yellow flowers are borne in a dense spike partly hidden among pale green to pink upper bracts. The branching, knobbly rhizome has a bright orange-yellow interior, the source of turmeric spice and dye.[1]
A tough, deep-rooted perennial herb or low subshrub of the pea family, 30-80 cm tall, sometimes bearing soft spines. It has a very long, woody, tenacious taproot - so strong it was said to stop (arrest) the harrow, giving 'rest-harrow' its name. The stems are hairy and sticky, often reddish, and clothed in small trifoliolate (clover-like) leaves with toothed leaflets. The flowers are typical pea flowers, pink to purplish-pink (occasionally white), borne singly or in pairs in the leaf axils. Field restharrow (O. arvensis) is generally less spiny than its close relative spiny restharrow (O. spinosa).[8, 10]
Habitat
Native to South Asia (India) and Southeast Asia; cultivated extensively in warm, humid tropical climates on well-drained, fertile soils.
Rough grassland, field margins, roadsides, dunes and dry, sandy or calcareous waste ground across Europe, western Asia and parts of North Africa. As a deep-rooted, nitrogen-fixing legume it colonises poor, disturbed soils and was historically a troublesome weed of arable fields (hence 'restharrow').[8]
Harvesting
The rhizomes are dug at the end of the growing season, typically 8-10 months after planting, when the leaves have died back; they are cleaned, boiled or steamed, then dried and often ground into the familiar yellow powder.
The root (Ononidis radix) is the principal medicinal part, dug in autumn from the second year onward and dried; the aerial flowering parts are also gathered in summer. The long woody taproot is cleaned and cut before drying for decoctions and infusions.[8]
Traditional Uses
Turmeric rhizome is a cornerstone spice and medicine of Ayurvedic and traditional Chinese medicine, used for millennia as an anti-inflammatory, digestive and wound-healing remedy and valued as a golden dye; its curcuminoid-rich rhizome is now among the most extensively researched botanicals for inflammatory and joint conditions, directly building on this traditional reputation.[1, 13]
Restharrow root has a long place in European herbal medicine as a gentle aquaretic diuretic used for 'irrigation therapy' of the urinary tract - to increase urine flow in cystitis, urinary gravel and stones, and to flush the bladder. Field restharrow (Ononis arvensis) is used interchangeably with the officinal spiny restharrow (O. spinosa, Ononidis radix). The root and flowering herb have also been used as a mild anti-inflammatory, for skin complaints and eczema, for rheumatic conditions, and (as a decoction or gargle) for the mouth and throat. The isoflavone-rich root is a folk remedy in central and eastern European traditions.[8, 13]
Preparations
Rhizome extract standardised to curcuminoid content, often combined with piperine (black pepper extract) to improve absorption, taken as capsules; the form used in most clinical arthritis and inflammation studies.
The dried root simmered in water and taken as an aquaretic diuretic for irrigation of the urinary tract; the classic restharrow preparation.
The flowering aerial parts infused as a milder diuretic and anti-inflammatory tea.
A root decoction used traditionally as a mouth/throat gargle and as a wash for skin complaints.
Dosage
Clinical trials in arthritis commonly use around 1000-1500 mg of curcumin (or curcuminoid-standardised extract) daily, in divided doses, often combined with piperine. Educational reference only, not a prescription.
Not documented
References
Drug Class Interactions
Lookalikes Review
Synonyms
Not documented
Pairings
Not documented
Classic urinary irrigation-therapy pairing: both are aquaretic diuretics used to increase urine flow in cystitis and urinary gravel.[13]
Both are traditional diuretic 'flushing' herbs for irrigation therapy of the urinary tract.[13]
Both are Fabaceae rich in the isoflavone phytoestrogen formononetin; combined use adds to phytoestrogen exposure - use caution in hormone-sensitive conditions.[1]
References & Sources
- Zeng, L., Yang, T., Yang, K., Yu, G. et al (2022) 'Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Frontiers in Immunology, 13, pp. 891822. doi:10.3389/fimmu.2022.891822 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.891822 - Zeng, L., Yu, G., Hao, W., Yang, K. and Chen, H (2021) 'The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis', Bioscience Reports, 41(6), pp. BSR20210817. doi:10.1042/BSR20210817 Meta-analysis / review
https://doi.org/10.1042/BSR20210817 - Marton, L.T., Pescinini-E-Salzedas, L.M., Camargo, M.E.C., Barbalho, S.M. et al (2021) 'The Effects of Curcumin on Diabetes Mellitus: A Systematic Review', Frontiers in Endocrinology, 12, pp. 669448. doi:10.3389/fendo.2021.669448 Meta-analysis / review
https://doi.org/10.3389/fendo.2021.669448 - Kocaadam, B. and Sanlier, N (2017) 'Curcumin, an active component of turmeric (Curcuma longa), and its effects on health', Critical Reviews in Food Science and Nutrition, 57(13), pp. 2889-2895. doi:10.1080/10408398.2015.1077195 Meta-analysis / review
https://doi.org/10.1080/10408398.2015.1077195 - Vaughn, A.R., Branum, A. and Sivamani, R.K (2016) 'Effects of turmeric (Curcuma longa) on skin health: a systematic review of the clinical evidence', Phytotherapy Research, 30(8), pp. 1243-1264. doi:10.1002/ptr.5640 Meta-analysis / review
https://doi.org/10.1002/ptr.5640 - Soleimani, V., Sahebkar, A. and Hosseinzadeh, H (2018) 'Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review', Phytotherapy Research, 32(6), pp. 985-995. doi:10.1002/ptr.6054 Meta-analysis / review
https://doi.org/10.1002/ptr.6054 - Zeng, L., Yang, T., Yang, K., Yu, G., Li, J., Xiang, W. and Chen, H (2022) 'Curcumin and Curcuma longa extract in the treatment of 10 types of autoimmune diseases: a systematic review and meta-analysis of 31 randomized controlled trials', Frontiers in Immunology, 13, pp. 896476. doi:10.3389/fimmu.2022.896476 Meta-analysis / review
https://doi.org/10.3389/fimmu.2022.896476 - Razavi, B.M., Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2021) 'A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents', Phytotherapy Research, 35(12), pp. 6489-6513. doi:10.1002/ptr.7224 Meta-analysis / review
https://doi.org/10.1002/ptr.7224 - Memarzia, A., Khazdair, M.R., Behrouz, S., Gholamnezhad, Z., Jafarnezhad, M., Saadat, S. and Boskabady, M.H (2021) 'Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review', BioFactors, 47(3), pp. 311-350. doi:10.1002/biof.1716 Meta-analysis / review
https://doi.org/10.1002/biof.1716 - Jurenka, J.S (2009) 'Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research', Alternative Medicine Review, 14(2), pp. 141-153. Meta-analysis / review
https://scholar.google.com/scholar?q=Anti-inflammatory%20properties%20of%20curcumin%2C%20a%20major%20constituent%20of%20Curcuma%20longa%3A%20a%20review%20of%20preclinical%20and%20clinical%20research - Hosseini, A. and Hosseinzadeh, H (2018) 'Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: a review', Biomedicine & Pharmacotherapy, 99, pp. 411-421. doi:10.1016/j.biopha.2018.01.072 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2018.01.072 - Araujo, C.C. and Leon, L.L (2001) 'Biological activities of Curcuma longa L', Memorias do Instituto Oswaldo Cruz, 96(5), pp. 723-728. doi:10.1590/s0074-02762001000500026 Meta-analysis / review
https://doi.org/10.1590/s0074-02762001000500026 - Aggarwal, B.B. and Harikumar, K.B (2009) 'Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases', 41(1), pp. 40--59. doi:10.1016/j.biocel.2008.06.010 Traditional / reference
https://doi.org/10.1016/j.biocel.2008.06.010 - Shoba, G. et al (1998) 'Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers', 64(4), pp. 353--356. doi:10.1055/s-2006-957450 Clinical study
https://doi.org/10.1055/s-2006-957450 - WHO (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Liu, A.C., Zhao, L.X. and Lou, H.X (2013) 'Curcumin alters the pharmacokinetics of warfarin and clopidogrel in Wistar rats but has no effect on anticoagulation or antiplatelet aggregation', Planta Medica, 79(11), pp. 971-977. doi:10.1055/s-0032-1328652 Preclinical
https://doi.org/10.1055/s-0032-1328652 - Tian, J., Feng, B. and Tian, Z (2022) 'The Effect of Curcumin on Lipid Profile and Glycemic Status of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Evidence-Based Complementary and Alternative Medicine, 2022, pp. 8278744. doi:10.1155/2022/8278744 Meta-analysis / review
https://doi.org/10.1155/2022/8278744 - Willcox, M.L., Elugbaju, C., Al-Anbaki, M., Lown, M. and Graz, B (2021) 'Effectiveness of Medicinal Plants for Glycaemic Control in Type 2 Diabetes: An Overview of Meta-Analyses of Clinical Trials', Frontiers in Pharmacology, 12, pp. 777561. doi:10.3389/fphar.2021.777561 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.777561 - Altobelli, E., Angeletti, P.M., Marziliano, C., Mastrodomenico, M., Giuliani, A.R. and Petrocelli, R (2021) 'Potential therapeutic effects of curcumin on glycemic and lipid profile in uncomplicated type 2 diabetes: a meta-analysis of randomized controlled trials', Nutrients, 13(2), pp. 404. doi:10.3390/nu13020404 Meta-analysis / review
https://doi.org/10.3390/nu13020404
- Gampe, N. and Darcsi, A. and Nagyne Nedves, A. and Boldizsar, I. and Kursinszki, L. and Beni, S (2019) 'Phytochemical analysis of Ononis arvensis L. by liquid chromatography coupled with mass spectrometry', Journal of Mass Spectrometry, 54(2), pp. 121-133. doi:10.1002/jms.4308 Preclinical
https://doi.org/10.1002/jms.4308 - Denes, T. and Bartha, S.G. and Kerenyi, M. and Varga, E. and Balazs, V.L. and Csepregi, R. and Papp, N (2017) 'Histological and antimicrobial study of Ononis arvensis L', Acta Biologica Hungarica, 68(3), pp. 321-333. doi:10.1556/018.68.2017.3.9 Preclinical
https://doi.org/10.1556/018.68.2017.3.9 - Gampe, N. and Nagy, E. and Kursinszki, L. and Beni, S (2021) 'Quantitative determination of isoflavonoids in Ononis species by UPLC-UV-DAD', Phytochemical Analysis, 32(4), pp. 474-481. doi:10.1002/pca.2995 Preclinical
https://doi.org/10.1002/pca.2995 - Gampe, N. and Szakacs, Z. and Darcsi, A. and Boldizsar, I. and Szoke, E. and Kuzovkina, I. and Kursinszki, L. and Beni, S (2021) 'Qualitative and Quantitative Phytochemical Analysis of Ononis arvensis Hairy Root Cultures', Frontiers in Plant Science, 11, pp. 622585. doi:10.3389/fpls.2020.622585 Preclinical
https://doi.org/10.3389/fpls.2020.622585 - Pazdziora, W. and Grabowska, K. and Zagrodzki, P. and Pasko, P. and Prochownik, E. and Podolak, I. and Galanty, A (2025) 'Quantitative Analysis of Isoflavones from Ononis Species and Their Chemopreventive Potential on Breast Cancer Cells', Molecules, 30(11), pp. 2379. doi:10.3390/molecules30112379 Preclinical
https://doi.org/10.3390/molecules30112379 - Spilkova, J. and Bednar, P. and Stroblikova, R (2001) 'Capillary electrophoretic analysis of hydroxycinnamic acids from Ononis arvensis L', Die Pharmazie, 56(5), pp. 424-425. Preclinical
https://scholar.google.com/scholar?q=Capillary%20electrophoretic%20analysis%20of%20hydroxycinnamic%20acids%20from%20Ononis%20arvensis%20L. - Spilkova, J. and Hubik, J (1982) 'Pharmacognosy study of Ononis arvensis L. II. Flavonoids and onocerin in the drug', Ceskoslovenska Farmacie, 31(1), pp. 24-26. Preclinical
https://scholar.google.com/scholar?q=Pharmacognosy%20study%20of%20Ononis%20arvensis%20L.%20II.%20Flavonoids%20and%20onocerin%20in%20the%20drug - Rezacova, A. and Spilkova, J. and Hubik, J (1978) 'A pharmacognostic study of the species Ononis arvensis L', Ceskoslovenska Farmacie, 27(10), pp. 452-455. Traditional / reference
https://scholar.google.com/scholar?q=A%20pharmacognostic%20study%20of%20the%20species%20Ononis%20arvensis%20L. - Felsberg, A.A. and Rosentsveig, P.E (1965) 'A comparative phytochemical study of the roots of Ononis arvensis L. and Ononis spinosa L', Aptechnoe Delo, 14(6), pp. 26-32. Preclinical
https://scholar.google.com/scholar?q=A%20comparative%20phytochemical%20study%20of%20the%20roots%20of%20Ononis%20arvensis%20L.%20and%20Ononis%20spinosa%20L. - Sichinava, M.B. and Mchelidze, K.Z. and Churadze, M.V. and Alaniia, M.D. and Aneli, D.N (2014) 'Chemical composition and microstructural peculiarities of overground and underground vegetative organs of field restharrow (Ononis arvensis L.)', Georgian Medical News, (231), pp. 88-94. Preclinical
https://scholar.google.com/scholar?q=Chemical%20composition%20and%20microstructural%20peculiarities%20of%20overground%20and%20underground%20vegetative%20organs%20of%20field%20restharrow%20%28Ononis%20arvensis%20L.%29 - Dedio, I. and Kozlowski, J (1977) 'Comparative morphological and phytochemical studies of Ononis spinosa L. and Ononis arvensis L. I. Biometric and chromatographic studies of methanolic extracts', Acta Poloniae Pharmaceutica, 34(1), pp. 97-102. Preclinical
https://scholar.google.com/scholar?q=Comparative%20morphological%20and%20phytochemical%20studies%20of%20Ononis%20spinosa%20L.%20and%20Ononis%20arvensis%20L.%20I.%20Biometric%20and%20chromatographic%20studies%20of%20methanolic%20extracts - Felsberg, A.A. and Rozentsveig, P.E (1965) 'Photochemical examination of Ononis arvensis. I', Aptechnoe Delo, 14(3), pp. 25-27. Preclinical
https://scholar.google.com/scholar?q=Photochemical%20examination%20of%20Ononis%20arvensis.%20I - Nechita, V. and Tarau, A. and Suster, A. and Nechita, M. and Toiu, A. and Benedec, D. and Hanganu, D. and Siserman, C. and Drugan, C. and Oniga, I (2026) 'Phytochemical Constituents and Biological Activities of Ononis spinosa: A Comprehensive Review', Plants (Basel), 15(9), pp. 1409. doi:10.3390/plants15091409 Meta-analysis / review
https://doi.org/10.3390/plants15091409 - Spiegler, V. and Gierlikowska, B. and Saenger, T. and Addotey, J.N. and Sendker, J. and Jose, J. and Kiss, A.K. and Hensel, A (2020) 'Root Extracts From Ononis spinosa Inhibit IL-8 Release Via Interactions With Toll-Like Receptor 4 and Lipopolysaccharide', Frontiers in Pharmacology, 11, pp. 889. doi:10.3389/fphar.2020.00889 Preclinical
https://doi.org/10.3389/fphar.2020.00889 - Deipenbrock, M. and Sendker, J. and Hensel, A (2020) 'Aqueous Root Extract from Ononis spinosa Exerts Anti-adhesive Activity against Uropathogenic Escherichia coli', Planta Medica, 86(4), pp. 247-254. doi:10.1055/a-1089-8645 Preclinical
https://doi.org/10.1055/a-1089-8645 - Ergene Oz, B. and Saltan Iscan, G. and Kupeli Akkol, E. and Suntar, I. and Bahadir Acikara, O (2017) 'Isoflavonoids as wound healing agents from Ononidis Radix', Journal of Ethnopharmacology, 211, pp. 384-393. doi:10.1016/j.jep.2017.09.029 Preclinical
https://doi.org/10.1016/j.jep.2017.09.029 - Arnold, E. and Benz, T. and Zapp, C. and Wink, M (2015) 'Inhibition of Cytosolic Phospholipase A2alpha (cPLA2alpha) by Medicinal Plants in Relation to Their Phenolic Content', Molecules, 20(8), pp. 15033-15048. doi:10.3390/molecules200815033 Preclinical
https://doi.org/10.3390/molecules200815033 - Yilmaz, B.S. and Ozbek, H. and Citoglu, G.S. and Ugras, S. and Bayram, I. and Erdogan, E (2006) 'Analgesic and hepatotoxic effects of Ononis spinosa L', Phytotherapy Research, 20(6), pp. 500-503. doi:10.1002/ptr.1891 Preclinical
https://doi.org/10.1002/ptr.1891 - Manal Ahmad, A. and Yasser Ibrahim, K. and Manal Mohammad, A (2021) 'Efficacy of extract from Ononis spinosa L. on ethanol-induced gastric mucosal injury in rats', Journal of Traditional Chinese Medicine, 41(2), pp. 270-275. Preclinical
https://scholar.google.com/scholar?q=Efficacy%20of%20extract%20from%20Ononis%20spinosa%20L.%20on%20ethanol-induced%20gastric%20mucosal%20injury%20in%20rats - Addotey, J.N. and Lengers, I. and Jose, J. and Gampe, N. and Beni, S. and Petereit, F. and Hensel, A (2018) 'Isoflavonoids with inhibiting effects on human hyaluronidase-1 and norneolignan clitorienolactone B from Ononis spinosa L. root extract', Fitoterapia, 130, pp. 169-174. doi:10.1016/j.fitote.2018.08.013 Preclinical
https://doi.org/10.1016/j.fitote.2018.08.013 - Stojković, D. and Drakulić, D. and Gašić, U. and Zengin, G. and Stevanović, M. and Rajčević, N. and Sokóvić, M (2020) 'Ononis spinosa L., an edible and medicinal plant: UHPLC-LTQ-Orbitrap/MS chemical profiling and biological activities of the herbal extract', Food & Function. doi:10.1039/d0fo01595d Preclinical
https://doi.org/10.1039/d0fo01595d - Stojković, D. and Días, M.I. and Drakulić, D. and Barros, L. and Stevanović, M. and Ferreira, I.C. and Sokóvić, M (2020) 'Methanolic Extract of the Herb Ononis spinosa L. Is an Antifungal Agent with no Cytotoxicity to Primary Human Cells', Pharmaceuticals. doi:10.3390/ph13040078 Preclinical
https://doi.org/10.3390/ph13040078 - Kırmızıgül, S. and Gören, N. and Yang, S. and Cordell, G.A. and Bozok-Johansson, C (1997) 'Spinonin, a Novel Glycoside from Ononis spinosa subsp. leiosperma', Journal of Natural Products. doi:10.1021/np9605652 Preclinical
https://doi.org/10.1021/np9605652 - Mladenova, S.G. and Savova, M.S. and Marchev, A.S. and Ferrante, C. and Orlando, G. and Wabitsch, M. and Georgiev, M.I (2022) 'Anti-adipogenic activity of maackiain and ononin is mediated via inhibition of PPARγ in human adipocytes', Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2022.112908 Preclinical
https://doi.org/10.1016/j.biopha.2022.112908 - Лужанин, В.Г. and Whaley, A.K. and Ponkratova, A.O. and Grishukova, E.A. and Suloev, I.S. and Смирнов, С.Н. and Serebryakov, E.B (2021) 'Isolation of Individual Compounds from the Terrestrial Parts of Ononis Arvensis L. and Solidago Canadensis L', Drug development & registration. doi:10.33380/2305-2066-2021-10-1-83-89 Preclinical
https://doi.org/10.33380/2305-2066-2021-10-1-83-89 - Bogoutdinova, A. and Whaley, A.K. and Ponkratova, A.O. and Orlova, A. and Goncharov, M.Y. and Shpakova, V. and Farmanova, N.T. and Nurullaeva, D.K. and Sharipov, A. and Gambaryan, S. and Повыдыш, М.Н (2021) 'Isolation of formononetin-7-O-β-D-glucopyranoside from the grass of Ononis arvensis L. and the assessment of its effect on induced platelet activation', Drug development & registration. doi:10.33380/2305-2066-2021-10-4(1)-14-19 Preclinical
https://doi.org/10.33380/2305-2066-2021-10-4(1)-14-19 - Paździora, W. and Grabowska, K. and Paśko, P. and Prochownik, E. and Podolak, I. and Galanty, A (2026) 'Multifaceted Evaluation of Isoflavone-Rich Fabaceae Species in Prostate Cancer In Vitro Models', Applied Sciences. doi:10.3390/app16136289 Preclinical
https://doi.org/10.3390/app16136289 - Gallo, G. and Cicione, A. and Nacchia, A. and Lombardo, R. and Riolo, S. and Guercio, A. and Fiasconaro, D. and Nunzio, C.D (2026) 'A randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms', Urologia Journal. doi:10.1177/03915603261454171 Randomized trial
https://doi.org/10.1177/03915603261454171 - Ismailov, E. and Рогожникова, Е. and Марданлы, С.Г. and Мизина, П. and Kalinina, T.S (2024) 'COMPARATIVE STUDY OF SETTINGS FROM WILD SPECIES OF STEELWORM', Problems of Biological Medical and Pharmaceutical Chemistry. doi:10.29296/25877313-2024-12-02 Preclinical
https://doi.org/10.29296/25877313-2024-12-02 - Mauro, E.D. and Saldutto, P. and Rocca, R.L. and Sangiorgi, G. and Patelli, G. and Barone, B. and Verratti, V. and Castellucci, R. and Napolitano, L. and Iacono, F. and Altieri, V (2024) 'Efficacy and Safety of Boldine Combined with Phyllanthus niruri and Ononis spinosa in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Single-Center, Retrospective Cohort Study', Medicina. doi:10.3390/medicina60091455 Clinical study
https://doi.org/10.3390/medicina60091455 - DÉNES, T (2022) 'PHYTOCHEMICAL INVESTIGATION AND ANTIOXIDANT POTENTIAL OF ONONIS ARVENSIS L', FARMACIA. doi:10.31925/farmacia.2022.3.20 Preclinical
https://doi.org/10.31925/farmacia.2022.3.20 - Zarga, M.H.A. and Al‐Jaber, H.I. and Al‐Qudah, M.A. and Al-Aboudi, A.M (2021) 'A new cyclic polyketide and other constituents from Ononis spinosa growing wildly in Jordan and their antioxidant activity', Journal of Asian Natural Products Research. doi:10.1080/10286020.2021.1914597 Preclinical
https://doi.org/10.1080/10286020.2021.1914597 - Abbas, M.A. and Jaffal, S.M (2019) 'ANTINOCICEPTIVE ACTION OF ONONIS SPINOSA LEAF EXTRACT IN MOUSE PAIN MODELS', Acta Poloniae Pharmaceutica - Drug Research. doi:10.32383/appdr/99291 Preclinical
https://doi.org/10.32383/appdr/99291 - (2009) 'Radical scavenger and Antioxidant activities of extracts and fractions from Bulgarian Ononis spinosa L. and GC-MS analysis of Ethanol extract', The Internet Journal of Alternative Medicine. doi:10.5580/121d Preclinical
https://doi.org/10.5580/121d - Davitavyan, N. and Е.Б., Н. and Pogulyay, Y. and Khochava, M. and Мизина, П. and Адамов, Г (2024) 'STUDYING THE HYPOLYPIDEMIC ACTIVITY OF FLAVONOIDS AND ISOFLAVONOIDS OF THE ONONIS ARVENSIS L. METHODS BY IN SILICO', Problems of Biological Medical and Pharmaceutical Chemistry. doi:10.29296/25877313-2024-05-01 Preclinical
https://doi.org/10.29296/25877313-2024-05-01 - Gampe, N. and Dávid, D.N. and Takács‐Novák, K. and Backlund, A. and Béni, S (2022) 'In vitro and in silico evaluation of Ononis isoflavonoids as molecules targeting the central nervous system', PLoS ONE. doi:10.1371/journal.pone.0265639 Preclinical
https://doi.org/10.1371/journal.pone.0265639 - Pauli, G.F (2000) 'Comprehensive Spectroscopic Investigation of α-Onocerin', Planta Medica. doi:10.1055/s-2000-14895 Preclinical
https://doi.org/10.1055/s-2000-14895 - Köster, J. and Strack, D. and Barz, W (1983) 'High Performance Liquid Chromatographic Separation of Isoflavones and Structural Elucidation of Isoflavone 7-O-glucoside 6″-malonates from Cicer arietinum', Planta Medica. doi:10.1055/s-2007-969907 Preclinical
https://doi.org/10.1055/s-2007-969907 - Spiegler, V. and Michalak, B. and Addotey, J.N. and Saenger, T. and Jose, J. and Kiss, A.K. and Hensel, A (2019) 'Root extracts from Ononis spinosa exert anti-inflammatory activity in vitro on IL-8 and TNF-α release by inhibition of TLR-4 receptor', Planta Medica. doi:10.1055/s-0039-3399691 Preclinical
https://doi.org/10.1055/s-0039-3399691 - Çoban, T. and Çitoğlu, G.S. and Yılmaz, B.S. and İşcan, M (2003) 'Antioxidant Activities of Plants Used in Traditional Medicine in Turkey', Pharmaceutical Biology. doi:10.1080/13880200390501974 Preclinical
https://doi.org/10.1080/13880200390501974 - Obiștioiu, D. and Cocan, I. and Tîrziu, E. and Herman, V. and Negrea, M. and Ban-Cucerzan, A. and Neacşu, A. and Cozma, A. and Nichita, I. and Hulea, A. and Radulov, I. and Alexa, E (2021) 'Phytochemical Profile and Microbiological Activity of Some Plants Belonging to the Fabaceae Family', Antibiotics. doi:10.3390/antibiotics10060662 Preclinical
https://doi.org/10.3390/antibiotics10060662 - Orlando, G. and Chiavaroli, A. and Ferrante, C. and Recinella, L. and Leone, S. and Brunetti, L. and Simone, S.C.D. and Menghini, L. and Petrucci, M. and Zengin, G. and Cesaroni, F. and Pontarelli, G. and Cindolo, L. and Neri, F (2021) 'Protective effects induced by the food supplement Fluxonorm® in the lower urinary tract', PubMed. doi:10.26355/eurrev_202104_25562 Preclinical
https://doi.org/10.26355/eurrev_202104_25562
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.